When Kim Kardashian posted a photo of herself in Prenuvo’s signature grey scrubs in August 2023, captioning it “I recently did this @prenuvo scan and had to tell you all about this life-saving machine,” it wasn’t so much a wellness recommendation as a cultural moment. Prenuvo, for the uninitiated, is a US-based health start-up offering full-body MRI scans to anyone willing to pay, no doctor’s referral required. Within days of Kardashian’s post, sign-ups spiked.
But Kardashian wasn’t even the first. Miranda Kerr had posted her Prenuvo visit in January of that year, Ian Somerhalder in February, Paris Hilton had given the company her own shout-out, and Kris Jenner got scanned on the family’s Hulu show. But Kardashian’s post, with its million-follower reach, was the real turning point, landing the full-body MRI squarely in the same conversation as cold plunging, continuous glucose monitoring and wearable health trackers.

The appeal is easy to understand. Lie in a machine for an hour – no radiation, no needles – and receive a detailed report on everything from your brain to your pelvis, potentially catching something serious before it has a chance to become catastrophic. Companies like Prenuvo and Ezra, both now with locations in several countries, claim their scans can screen for more than 500 conditions, including tumours, aneurysms and early signs of multiple sclerosis. Prenuvo’s flagship scan starts at around US$2,500. Ezra recently launched what it calls the world’s first 30-minute full-body MRI, powered by FDA-cleared AI. Neither is covered by insurance.
Which raises the obvious question: what exactly are you getting? “A full-body MRI is an anatomical scan that takes detailed pictures of the structures of your body using magnetic fields and radio waves, without radiation exposure,” explains Dr Matthew Potts, clinical director of the Dorsi Spinal Institute. Think of it as like a high-resolution photograph of your insides. “It is very good at showing the size and shape of tissues and organs, so it can sometimes detect larger masses or structural changes that have already grown to a visible size,” Potts says. The flip side of that, he notes, is that “something has to be there at a certain size before MRI can see it, which means it is not automatically ‘early’ detection in the way most people assume”.

That gap between expectation and reality is worth considering. One thing these scans are quite good at surfacing is what radiologists call incidental findings, or, more evocatively, “incidentalomas”: abnormalities that show up on a scan that weren’t causing any symptoms and, in many cases, never would have. A small cyst on your kidney. A disc bulge in your spine. Findings that are real, but may have no bearing whatsoever on how you feel or how long you live. Potts points out that disc bulges and protrusions appear in 20 to 30 per cent of people with no pain at all, and that knee MRIs in people without symptoms show abnormalities in more than 90 per cent of cases. For a patient reading their report, “abnormal” doesn’t automatically mean something to treat. It can just mean “human”.
There’s also a subtler issue around what it means to scan something versus actually screen for it. MRI safety expert Tobias Gilk explains, “Different settings are used to look for different types of abnormalities. Just because there was imaging of a patient’s heart doesn’t mean that a single imaging pass is equally effective at looking for signs of blockage, tissue damage or a faulty valve.” It’s less a flaw in the technology and more a reminder that breadth and depth aren’t the same thing.

So what can these scans realistically find? Larger soft tissue masses, significant aneurysms, major structural abnormalities in the brain or spine: the kinds of things that have grown to a detectable size without yet producing obvious symptoms. That’s a genuinely meaningful window. Prenuvo says one in 20 of its scans results in a potentially life-saving diagnosis, and there are real stories behind that number. TV host Maria Menounos, for instance, has credited a Prenuvo scan with catching her stage 2 pancreatic cancer.
What the scans are less equipped for: microscopic or very early-stage cancers, inflammatory and autoimmune conditions, most metabolic and hormonal issues, and anything where the problem is about how the body is functioning rather than what it looks like. There’s also a more difficult question around cancer detection specifically.
For now, the medical establishment is watching carefully. No major medical or radiology establishment has endorsed whole-body MRI as a routine screening tool for asymptomatic patients. “Whole-body MRI as a screening tool is of enormous potential benefit, but today there’s not a body of data to clearly demonstrate those benefits,” Gilk says.

Potts suggests working through a few questions with your doctor first. Do you have specific symptoms or risk factors that make targeted investigation worthwhile, or are you essentially well and just curious? Are there established screening programmes better suited to your situation, like a mammogram or colonoscopy, which carry decades of outcome data? And perhaps most importantly: are you prepared for the real possibility of an incidental finding, and everything that can come after it? “For many people, once they work through those questions honestly,” he says, “the attraction of a full-body MRI fades.”
None of which is to say the impulse behind these scans is wrong. In a healthcare system that’s historically been better at treating illness than anticipating it, wanting to get ahead of something before it gets ahead of you is a completely reasonable instinct. The longevity conversation is moving into the mainstream, and these scans are a key part of that debate.

Original source: hk